Description: Atomoxetine is a selective norepinephrine reuptake inhibitor (SNRI) approved as a less stimulating treatment for ADHD in 2002 (U.S.). The precise mechanism by which it produces its therapeutic effects is unknown, but is thought to be related to its SNRI action. ((-)-N-methyl-3-phenyl-3-(o-tolyloxy)-propylamine)
Content-type: application/atom+xml
breaking drug news - atomoxetine2009-11-20T21:50:45ZDrugSense News Bothttp://drugpolicycentral.com/bot/XML::Atom::SimpleFeedVardenafil: A Potential Drug To Protect Gastric Mucosa (US) Study Finds Opiates More Effective in Elderly 2009-11-18T13:35:32Zhttp://drugpolicycentral.com/bot/article/redorbit9520.htm
How does this newsbot work for you? We are especially interested in hearing from you about this site. What do you like about it? What don't you like about this site? What would you change about this site? Please write and let us know how we are doing.
![:-] Bot! - home](/bot/images/dsbotface1.gif ":-] Bot! - home")
